August 27, 2025
Living Diagnostics
The blog that connects you with the in vitro diagnostic world.
Latest Articles
Swipe for more articles
-
February 11, 2026
Is Flu/COVID/RSV Testing Enough? A Comparison of Multiplex Respiratory Testing
This articles features a comparison of the performance of BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV, and Cobas® SARS-CoV-2 & Influenza A/B assay for detection of respiratory viruses.
-
December 11, 2025
Fast Antimicrobial Susceptibility Testing
In this article, we delve into the benefits of fast AST and explore why it has the potential to bridge the critical gap in BSI and sepsis management. -
November 13, 2025
Two Hours Saved, Antibiotics Reduced: The Strong Case for a Novel Rapid Multiplex PCR in the ED
The Academic Emergency Medicine journal has published a study that investigates the effectiveness of a rapid (approximately 15–minute turnaround) 15-plex PCR respiratory panel in emergency department (ED) patients with suspected ARI. Below we summarize the key findings.
-
July 16, 2025
A new chapter in Quality Control – how USP Chapter <86> can transform approaches to endotoxin testing
Could 2025 be the year that endotoxin testing finally catches up with the 21st century? Unlike other areas of Pharmaceutical Quality Control where innovations such as data analytics and automation have driven extensive modernization, endotoxin testing has remained resolutely stuck in the past. This vital Quality Control procedure has until recently relied on outdated testing practices that require the blood of horseshoe crabs. Significantly, new authoritative standards have recently recognized alternative testing methods that can deliver the same important validation, without relying on animal-derived products. What are these new standards and what could their integration mean for the future of endotoxin testing?